Home › Diffuse Large B-Cell Lymphoma › Oregon › Eugene
Diffuse Large B-Cell Lymphoma clinical trials in Eugene, OR
3 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RecruitingPhase 3
- Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8001), Eugene
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RecruitingPhase 2
- Oncology Associates of Oregon, P.C, Eugene
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecruitingPhase 2
- Oncology Associates of Oregon, Eugene
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY20 studies
- Baldwin Park, CA19 studies
- Los Angeles, CA18 studies
- Houston, TX18 studies
- Chicago, IL18 studies
- Milwaukee, WI17 studies
- Nashville, TN17 studies
- Boston, MA17 studies
- Philadelphia, PA15 studies
- Durham, NC15 studies
- Portland, OR15 studies
- Cleveland, OH13 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer11 studies
- Ovarian Cancer10 studies
- Endometrial Cancer8 studies
- Metastatic Cancer6 studies
- Breast Cancer6 studies
- Cancer (all types)6 studies
- Multiple Myeloma6 studies
- Chronic Lymphocytic Leukemia6 studies
- Drug Use and Addiction5 studies
- Obesity4 studies
- Macular Degeneration4 studies
- Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.